These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14233312)

  • 21. [Mode of action and indication for appetite depressants in the treatment of obesity].
    Stauffacher W
    Schweiz Med Wochenschr; 1975 Apr; 105(15):461-6. PubMed ID: 1124373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drug addiction by abuse of the so-called appetite depressants (obesin)].
    ROSE W
    Arch Toxikol; 1959; 17():331-5. PubMed ID: 14438852
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of amphetamine combinations for appetite suppression.
    FREED SC; MIZEL M
    Ann Intern Med; 1952 Jun; 36(6):1492-7. PubMed ID: 14924480
    [No Abstract]   [Full Text] [Related]  

  • 24. Amphetamine-positive drug screens from use of clobenzorex hydrochlorate.
    Tarver JA
    J Anal Toxicol; 1994; 18(3):183. PubMed ID: 8065131
    [No Abstract]   [Full Text] [Related]  

  • 25. Phentermine: an appetite-suppressant amphetamine classified as a narcotic in France. Is a combination with topiramate on the horizon?
    Prescrire Int; 2012 Sep; 21(130):209. PubMed ID: 23016252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [CONTROLLED CLINICAL EVALUATION OF THE APPETITE DEPRESSANT, RO-4-5282/827, IN THE TREATMENT OF OBESITY].
    DE SALCEDO I
    J Med (Oporto); 1963 Dec; 52():771-6. PubMed ID: 14103552
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinic on poisoning.
    CARVER GM; DAVIDSON WC
    J Pediatr; 1948 Feb; 32(2):207-14. PubMed ID: 18899743
    [No Abstract]   [Full Text] [Related]  

  • 28. [Dextrogyral amphetamine in the treatment of obesity; a new appetite reducer without secondary effects].
    CASTELLUCCIO R
    Sem Med; 1950 Mar; 57(13):485-7. PubMed ID: 15413156
    [No Abstract]   [Full Text] [Related]  

  • 29. A clinical pharmacologic study of benzphetamine (didrex), a new appetite suppressant.
    OSTER HL; MEDLAR RE
    Ariz Med; 1960 Jul; 17():398-404. PubMed ID: 14429287
    [No Abstract]   [Full Text] [Related]  

  • 30. [The appetite problem and its control by amphetamine dextrogyrates in various types of obesity].
    ROJAS MUJICA G; DIAZ DE VALDES H; FERNANDEZ G
    Rev Med Chil; 1949 Jul; 77(7):444-8. PubMed ID: 18136562
    [No Abstract]   [Full Text] [Related]  

  • 31. [Contribution to a study of a new lipolytic and anorectic drug: fenproporex (author's transl)].
    Nájera Mortes J
    Folia Clin Int (Barc); 1973 Feb; 23(2):134-51. PubMed ID: 4804960
    [No Abstract]   [Full Text] [Related]  

  • 32. DRUG SENSITIVITY IN OBESITY: CLINICAL EXPERIENCES WITH THE SEVEN-QUESTION TEST.
    BIGSBY FL; MUNIZ C
    IMJ Ill Med J; 1964 Jun; 125():630-3. PubMed ID: 14175265
    [No Abstract]   [Full Text] [Related]  

  • 33. DRUGS FOR OBESITY.
    WILSON DR
    Can Med Assoc J; 1964 Dec; 91(26):1369. PubMed ID: 14228231
    [No Abstract]   [Full Text] [Related]  

  • 34. Amphetamine-resin complex for prolonged appetite suppression.
    FREED SC; KEATING JW; HAYS EE
    Ann Intern Med; 1956 Jun; 44(6):1136-41. PubMed ID: 13327801
    [No Abstract]   [Full Text] [Related]  

  • 35. A STUDY OF OBESITY IN GENERAL PRACTICE.
    BEW K
    Ulster Med J; 1964 Jun; 33(1):43-8. PubMed ID: 14177397
    [No Abstract]   [Full Text] [Related]  

  • 36. Khat use and appetite: an overview and comparison of amphetamine, khat and cathinone.
    Lemieux AM; Li B; al'Absi M
    J Ethnopharmacol; 2015 Feb; 160():78-85. PubMed ID: 25435289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [ON APPETITE DEPRESSANTS].
    LACHNIT V
    Wien Med Wochenschr; 1965 Jun; 115():471-3. PubMed ID: 14304580
    [No Abstract]   [Full Text] [Related]  

  • 38. The amphetamine appetite suppressant saga.
    Prescrire Int; 2004 Feb; 13(69):26-9. PubMed ID: 15055225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind study of an anorexigenic combination.
    ROSENBERG BA
    Curr Ther Res Clin Exp; 1961 Feb; 3():45-50. PubMed ID: 13743379
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of d-amphetamine to curb the increased appetite and over-eating induced by reserpine therapy.
    KINARD S; MILLS LC; MOYER JH; TERRELL J
    J Am Geriatr Soc; 1956 Nov; 4(11):1073-7. PubMed ID: 13376290
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.